Raymond James Starts Adaptimmune Therapeutics plc (ADAP) at Outperform

September 29, 2016 5:12 PM EDT
Get Alerts ADAP Hot Sheet
Price: $4.20 --0%

Rating Summary:
    6 Buy, 0 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 18 | New: 19
Trade ADAP Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Raymond James initiated coverage on Adaptimmune Therapeutics plc (NASDAQ: ADAP) with an Outperform rating and a price target of $16.00.

For an analyst ratings summary and ratings history on Adaptimmune Therapeutics plc click here. For more ratings news on Adaptimmune Therapeutics plc click here.

Shares of Adaptimmune Therapeutics plc closed at $7.30 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot New Coverage, New Coverage

Related Entities

Raymond James

Add Your Comment